You searched for metabolic diseases - Page 22 of 63

In Depth 18 Nov 2024

What is Abcam’s founder, Jonathan Milner, up to?

…AI Drug discovery, rare diseases Healx specializes in the use of artificial intelligence (AI) to accelerate the discovery and development of treatments for rare diseases with its platform Healnet. One…

November 18, 2024 - 17 minutesmins - By Jules Adam

immunoqure autoantibodies therapeutic apeced

News and Trends 19 Jul 2016

German Biotech studies Autoimmune Diseases to develop new Therapeutics

…(Switzerland), but for infectious diseases like Ebola. With this work, the approach could extend to autoimmune diseases. ImmunoQure already has 2 candidates in the late stages of preclinical development. It…

July 19, 2016 - 3 minutesmins - By Denise Neves Gameiro

In Depth 28 Nov 2017

Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?

Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix each of them. Here’s a review of biotech’s progress. Biotech is arguably built on…

November 28, 2017 - 8 minutesmins - By Evelyn Warner

News and Trends 21 Jul 2022

Almirall launches new call to find innovative therapies for skin diseases

A new call for new therapies to treat skin diseases has been launched by global Spanish-based biopharmaceutical company, Almirall, S.A. This is the seventh call through AlmirallShare – an open…

July 21, 2022 - 3 minutesmins - By Liza Laws

More News! 16 Apr 2018

Epitopes Come to the Rescue for One of the Most Common Autoimmune Diseases

The British-Belgian biotech Apitope has obtained positive Phase I results for its first-in-class treatment for Graves’ disease, one of the most common autoimmune diseases. Apitope has obtained positive clinical results…

April 16, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 2 Sep 2016

Vienna-based Themis Bioscience frontlines vaccine development against emerging diseases

…Founded: 2009 Employees: 4 Financial Data: €10M Total Raised (as of 12/2015) CEO: Erich Tauber Mission: Themis Bioscience targets emerging diseases, like Zika and Chikungunya, and aims to develop vaccines…

September 2, 2016 - 1 minutemin - By Evelyn Warner

News and Trends 22 Sep 2022

New phase 1 biomarker results reported by Glyscend Therapeutics for diabetes drug

…GLY-200 for the treatment of T2D and has initiated a phase 2 clinical trial in patients with the condition. Glyscend says that metabolic surgery is a highly effective but invasive…

September 22, 2022 - 4 minutesmins - By Liza Laws

Interview 11 Jul 2017

The Advantage for the First Mover in NASH is Limited, says Genfit

…enough,” said Hum. “As we see in other metabolic diseases, there’s a small number of patients in other metabolic diseases who are able to maintain that lifestyle.” “The point is…

July 11, 2017 - 4 minutesmins - By Evelyn Warner

Startup Scout 11 May 2018

This Oxford Biotech is Using DNA to Find New Peptide Drugs

…variety of indications, from oncology and autoimmune diseases to metabolic, cardiovascular and infectious diseases seems exciting. However, there are not many peptide drugs on the market. It will be interesting…

May 11, 2018 - 2 minutesmins - By Alexander Burik

Best in Biotech 6 Jun 2024

Eight biotech companies advancing the field of siRNA

…thereby preventing them from being translated into proteins. This specific mechanism has the potential to treat a wide range of diseases, from genetic disorders and cancers to viral infections. Unlike…

June 6, 2024 - 11 minutesmins - By Jules Adam

In Depth 14 Apr 2025

Metabolomics: The study of biology’s dark matter

…confined to a set of monomers, instead, they can be any small molecule resulting from metabolic reactions. “If genomics, transcriptomics, and proteomics are Lego kits, with metabolites you are now…

April 14, 2025 - 7 minutesmins - By Jules Adam

Best in Biotech 17 Sep 2024

Estonia: Seven biotech companies to reckon with

…potential of N6-methyladenosine (m6A), a chemical modification found in RNA that is implicated in various neurodegenerative and neuropsychiatric diseases, as well as cancer. Chemestmed’s work in epitranscriptomics aims to regulate…

September 17, 2024 - 7 minutesmins - By Jules Adam

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

What is Abcam’s founder, Jonathan Milner, up to?

German Biotech studies Autoimmune Diseases to develop new Therapeutics

Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?

Almirall launches new call to find innovative therapies for skin diseases

Epitopes Come to the Rescue for One of the Most Common Autoimmune Diseases

Vienna-based Themis Bioscience frontlines vaccine development against emerging diseases

New phase 1 biomarker results reported by Glyscend Therapeutics for diabetes drug

The Advantage for the First Mover in NASH is Limited, says Genfit

This Oxford Biotech is Using DNA to Find New Peptide Drugs

Eight biotech companies advancing the field of siRNA

Metabolomics: The study of biology’s dark matter

Estonia: Seven biotech companies to reckon with

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!